Healthcare - Biotechnology - NASDAQ - US
$ 2.27
-3.4 %
$ 128 M
Market Cap
-1.92
P/E
BALANCE SHEET
57.9 M
ASSETS
32.5 M
LIABILITIES
12.9 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Rani Therapeutics Holdings, Inc.
| Current Assets | 50.8 M |
| Cash & Short-Term Investments | 48.5 M |
| Receivables | 0 |
| Other Current Assets | 2.31 M |
| Non-Current Assets | 7.07 M |
| Long-Term Investments | 0 |
| PP&E | 6.82 M |
| Other Non-Current Assets | 246 K |
| Current Liabilities | 7.99 M |
| Accounts Payable | 648 K |
| Short-Term Debt | 6.33 M |
| Other Current Liabilities | 1.01 M |
| Non-Current Liabilities | 24.5 M |
| Long-Term Debt | 24.5 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 5.9 | 27.0 | 117.5 | 73.1 | 16.5 |
| Short Term Investments | 42.7 | 71.5 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 1.7 | 0.2 |
| Inventory | 0 | 0 | 0 | 0 | 1 |
| Other Current Assets | 2.3 | 2.4 | 2.1 | 0.2 | 0.2 |
| Total Current Assets | 50.8 | 100.9 | 119.6 | 74.9 | 16.9 |
| PP&E | 6.8 | 7.1 | 4.6 | 4.5 | 4.5 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 1.6 |
| Other Long Term Assets | 0.2 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 57.9 | 108.0 | 124.2 | 79.4 | 23.0 |
| LIABILITIES | |||||
| Accounts Payable | 0.6 | 1.5 | 1.1 | 0.5 | 0.2 |
| Short Term Debt | 6.3 | 2.0 | 0 | 1.4 | 0 |
| Other Current Liabilities | 1.0 | 1.3 | 1.6 | 0.7 | 3.1 |
| Total Current Liabilities | 8.0 | 4.8 | 2.6 | 5.3 | 3.5 |
| Long Term Debt | 24.5 | 29.2 | 0 | 2.4 | 115.5 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 185.0 | 0.7 |
| Total Liabilities | 32.5 | 34.0 | 2.6 | 192.8 | 119.7 |
| EQUITY | |||||
| Common Stock | 5 K | 5 K | 5 K | 0.7 | 0.7 |
| Retained Earnings | (72.9) | (38.9) | (8.3) | (114.0) | (97.3) |
| Other Accumulative Comprehensive Income/Loss | 12 K | 73 K | (124.2) | (0.8) | (0.8) |
| Total Equity | 25.4 | 74.0 | 121.6 | (113.3) | (96.6) |
| Total Liabilities and Equity | 57.9 | 108.0 | 124.2 | 79.4 | 23.0 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 25.5 | 23.8 | 19.7 | 19.7 | 19.7 |